FDA WARNING_LETTER - Dr. Berne’s Whole Health Products - August 21, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On November 22, 2023, the FDA issued a Warning Letter to Samuel Berne regarding products sold on https://shop.drsamberne.com/, specifically "Dr. Berne’s MSM Eye Drops 5%," "Dr. Berne’s MSM Eye Drops 15%," and "Dr. Berne’s MSM Eye Mist 15%."
The FDA determined these products are unapproved new drugs under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), because they are intended for disease treatment/prevention or to affect body structure/function, and are not generally recognized as safe and effective (GRASE). Introducing them into interstate commerce violates sections 301(d) and 505(a).
Furthermore, FDA laboratory testing of "Dr. Berne’s MSM Eye Drops 5%" (lot 6786) revealed microbial contamination, including Exophiala sp. and Bacillus spp., failing USP <71> sterility tests. This renders the product adulterated under section 501(a)(1) of the FD&C Act, 21 U.S.C. 351(a)(1), violating section 301(a). The FDA highlighted the high public health risk posed by contaminated ophthalmic products.
The company initiated
ID · c99b7890-d49a-4030-b76a-a852d6c9b058
Full citation text and observation details available on the Dashboard.